NovaBridge Biosciences Deferred Tax Assets, Operating Loss Carryforwards
NovaBridge Biosciences (NBP) had Deferred Tax Assets, Operating Loss Carryforwards of $44.73 million as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-04-07
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards 912.14M CNY.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards 792.60M CNY.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards 380.69M CNY.
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards 107.34M CNY.
CNY
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2023-12-31 | 912.14M CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 792.60M CNY 20-F · filed 2024-04-30 |
| 2021-12-31 | 380.69M CNY 20-F · filed 2023-05-01 |
| 2020-12-31 | 107.34M CNY 20-F · filed 2022-04-29 |
| 2019-12-31 | 136.44M CNY 20-F · filed 2021-04-28 |
| 2018-12-31 | 92.19M CNY 20-F · filed 2021-04-28 |
| 2017-12-31 | 73.11M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $44.73M 20-F · filed 2026-04-07 | |
| 2024-12-31 | $34.48M 20-F · filed 2026-04-07 | |
| 2023-12-31 | $25.19M 20-F · filed 2025-04-03 | $128.47M 20-F · filed 2024-04-30 |
| 2022-12-31 | $114.92M 20-F · filed 2023-05-01 | |
| 2021-12-31 | $59.74M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $16.45M 20-F · filed 2021-04-28 | |
| 2019-12-31 | $19.60M 20-F · filed 2020-04-29 |